N1-Headache
Commercial- Indications
- Migraine, Post-concussive headache
Company intelligence / Profile preview
Curelator has developed a digital health tool called N1‑Headache that enables personalized identification of migraine triggers and protectors using daily self-tracking and advanced analytics. The product has been used in multiple clinical studies and collaborations with academic centers such as NYU Langone Medical Center[4][6]. No traditional drug development pipeline; the focus is on digital intervention for chronic disease management. Clinical results have demonstrated the ability to help individuals identify both risk factors ("triggers") and protective behaviors or exposures ("protectors") for migraine attacks[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curelator.